19 January 2024
An open science competition held by a Canadian nonprofit has announced the discovery of molecules that could someday lead to new treatments for Parkinson’s disease.
MHRA approves ‘safer’ medicine alternative for rare disease
19 January 2024
A new drug has been approved in the UK as a safer alternative to corticosteroids to treat Duchenne muscular dystrophy (DMD).
Russia created the first ultrasound-guided facial injection model
18 January 2024
The Moscow Health Care Department’s Center for Diagnostics and Telemedicine Technologies has developed a face model specifically designed for honing injection techniques under ultrasound guidance. This is the first Russian model for training such manipulations, the center’s press service said.
Leading a New Era of Patient-Inspired Neuroscience
18 January 2024
The need for innovation in neuroscience remains urgent. Patients, families and communities around the world carry the massive burden of suffering caused by diseases and disorders of the central nervous system. Despite scientific progress in understanding the brain’s complexities, much remains to learn about its structure, function, and role in neurological and psychiatric disorders.
Researchers find key to clearing precancerous cells, and with it, a potential treatment mechanism
17 January 2024
Researchers have chipped away a little more at the mystery of cancer resistance, this time in the form of new findings that explain how the immune system senses DNA damage in precancerous cells.
Spectroscopy milestone signals advance in protein imaging
17 January 2024
An ultra-high sensitivity and super-resolution infrared imaging technique for single proteins could lead the way to a multitude of applications using infrared nanospectroscopy.
Achieving optimal advanced process control in bioproduction
16 January 2024
Model Predictive Control (MPC) “stands out as a beacon of advanced control” in continuous manufacturing, through its ability to enhance efficacy within bioproduction, research suggests.
FDA clears AI that predicts Alzheimer’s progression from an MRI scan
16 January 2024
The FDA has granted a de novo clearance to an artificial intelligence program capable of reading a standard brain MRI scan and predicting a patient’s chances of progressing from mild cognitive impairment and early memory loss to Alzheimer’s disease and dementia within five years, according to the software’s developer Darmiyan.
Vaccine demonstrates benefit in delaying cancer relapse
15 January 2024
Data from the Phase I trial showed that the cancer vaccine offered an 86 percent reduction in the risk of relapse or death in pancreatic and colorectal cancers.
New collaboration could transform neonatal therapy
12 January 2024
With no currently approved medicines for the prevention of bronchopulmonary dysplasia (BPD) in extremely pre-term infants, a new pharmaceutical collaboration could produce the first major therapeutic breakthrough for this patient group in decades.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024